MethOxyfluraNe in InTerventiOnal Radiology (MONITOR): A randomised controlled trial

Abstract

AbstractIntroductionProcedural sedation and pain management in interventional radiology (IR) are of critical importance to successful outcomes but remain under‐researched. Methoxyflurane has been previously used in some minor procedures with several advantages including rapid onset and offset and a good safety profile. The purpose of this study was to evaluate methoxyflurane for procedures in IR.MethodsA randomised, double‐blind, placebo‐controlled trial was performed between October 2021 and November 2022. Patients presenting for portacath insertion, portacath removal or solid organ biopsy were randomised to either methoxyflurane or placebo. Three hundred and fourteen patients were enrolled in total. Patients were supplied with one Penthrox inhaler containing either 3 mL methoxyflurane or placebo. The primary endpoints of the study were change in pain and anxiety scores compared with baseline, measured on a standardised visual analogue scale (VAS) pre‐procedure, at 5‐min intervals during the procedure and post‐procedure. Baselines scores were controlled for in the statistical analysis. Safety analysis was also performed.ResultsOne hundred and sixty‐nine patients received methoxyflurane and 145 received placebo. Baseline characteristics were similar between the two groups. The methoxyflurane group had lower pain and anxiety scores throughout the procedure (P < 0.001) with 2.5 times less pain (VAS 1.08/10) and 1.6 times less anxiety (VAS 0.97/10) on average. Lower post‐procedure pain (mean 0.72 vs 1.44; P < 0.001) and anxiety (mean 0.55 vs 1.13; P = 0.008) were also observed with methoxyflurane. There were no drug or major procedure‐related adverse events.ConclusionThe results of this study suggest that methoxyflurane provides safe and effective analgesia and anxiolysis for some procedures in IR.